64 related articles for article (PubMed ID: 22554429)
1. Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study.
Laundon W; Muzyk AJ; Gagliardi JP; Christopher EJ; Rothrock-Christian T; Jiang W
Gen Hosp Psychiatry; 2012; 34(4):380-4. PubMed ID: 22554429
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
4. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
[TBL] [Abstract][Full Text] [Related]
5. Metabolic monitoring of patients prescribed second-generation antipsychotics.
Dhamane AD; Martin BC; Brixner DI; Hudson TJ; Said Q
J Psychiatr Pract; 2013 Sep; 19(5):360-74. PubMed ID: 24042242
[TBL] [Abstract][Full Text] [Related]
6. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
7. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
[TBL] [Abstract][Full Text] [Related]
8. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.
Haupt DW; Rosenblatt LC; Kim E; Baker RA; Whitehead R; Newcomer JW
Am J Psychiatry; 2009 Mar; 166(3):345-53. PubMed ID: 19147694
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.
Vuksan-Ćusa B; Jakovljević M; Sagud M; Mihaljević Peleš A; Marčinko D; Topić R; Mihaljević S; Sertić J
Psychiatry Res; 2011 Aug; 189(1):21-5. PubMed ID: 21216014
[TBL] [Abstract][Full Text] [Related]
13. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan.
Chang HH; Chou CH; Chen PS; Gean PW; Huang HC; Lin CY; Yang YK; Lu RB
J Affect Disord; 2009 Sep; 117(1-2):124-9. PubMed ID: 19193445
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
DelMonte MT; Bostwick JR; Bess JD; Dalack GW
J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
[TBL] [Abstract][Full Text] [Related]
16. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
18. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
Hamann J; Pfeiffer H; Leucht S; Kissling W
Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
[TBL] [Abstract][Full Text] [Related]
19. Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.
Barnett M; VonMuenster S; Wehring H; Popish S; McDonald K; Walker VM; Perry P
Ann Clin Psychiatry; 2010 Feb; 22(1):9-18. PubMed ID: 20196978
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
